AbbVie Inc. (ETR:4AB)
189.20
+0.60 (0.32%)
Nov 7, 2025, 5:35 PM CET
AbbVie Revenue
AbbVie had revenue of $15.78B USD in the quarter ending September 30, 2025, with 9.10% growth. This brings the company's revenue in the last twelve months to $59.64B, up 7.40% year-over-year. In the year 2024, AbbVie had annual revenue of $56.33B with 3.71% growth.
Revenue (ttm)
$59.64B
Revenue Growth
+7.40%
P/S Ratio
6.58
Revenue / Employee
$1.08M
Employees
55,000
Market Cap
334.51B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 56.33B | 2.02B | 3.71% |
| Dec 31, 2023 | 54.32B | -3.74B | -6.44% |
| Dec 31, 2022 | 58.05B | 1.86B | 3.30% |
| Dec 31, 2021 | 56.20B | 10.39B | 22.69% |
| Dec 31, 2020 | 45.80B | 12.54B | 37.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 46.17B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.22B |
| Fresenius Medical Care AG | 19.64B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
AbbVie News
- 1 day ago - Healthcare Q3 Dividend Roundup: I Prefer AbbVie Over Pfizer - Seeking Alpha
- 3 days ago - VOO, JNJ, ABBV, HD: Large Inflows Detected at ETF - Nasdaq
- 4 days ago - $100 Invested In AbbVie 5 Years Ago Would Be Worth This Much Today - Benzinga
- 4 days ago - Ironwood wins FDA label expansion for bowel disease drug developed with AbbVie - Seeking Alpha
- 4 days ago - ABBV Receives New Price Target and Overweight Rating from Piper Sandler | ABBV Stock News - GuruFocus
- 4 days ago - Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know - Nasdaq
- 4 days ago - AbbVie (ABBV) Stock Signal: How Did Earnings Impact Its Outlook? - 05 November 2025 - DailyForex
- 4 days ago - Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight - GuruFocus